Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 1, 2005, Pages 1-2

  Roach III, MacK ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HUMAN; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION HAZARD; RADIOLOGIST; REDUCTION; STANDARD;

HUMANS; IMPOTENCE, VASCULOGENIC; MAGNETIC RESONANCE IMAGING; MALE; PENIS; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11144329599     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.05.038     Document Type: Editorial

References (10)

1. McLaughlin PW, Narayana V, Meriowitz A, et al. Vessel sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudental artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 2005;61:20-31.
2. M. Roach III, P. Faillace-Akazawa, C. Malfatti Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 35 1996 1011 1018
3. K. Kagawa, W.R. Lee, T.E. Schultheiss Clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy Int J Radiat Oncol Biol Phys 36 1996 246
4. M. Roach III, Perez C.A. Blasko JC Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria Radiology 215 2000 1441 1448
5. W.R. Lee, M. Roach III, J. Michalski Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy Int J Radiat Oncol Biol Phys 54 2002 457 461
6. M. Roach, B. Pickett, P. F-Akazawa Implementation of newer radiotherapeutic technology in the management of prostate cancer B. Mittal PurdyJ Advances in radiation therapy. Vol 1. 1st ed 1998 Kluwer Academic Publishers Norwell, MA 247 268
7. B.M. Fisch, B. Pickett, V. Weinberg Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer Urology 57 2001 955 959
8. G.S. Merrick, K. Wallner, W.M. Butler A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction Int J Radiat Oncol Biol Phys 50 2001 597 604
9. Roach M, Winter K, Michalski JM, et al. Penile bulb dose and impotence following 3D conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective multi-institutional Phase I-II dose escalation study. Int J Radiat Oncol Biol Phys 2004;60:1351-1356.
10. L.E. Millender, M. Aubin, J. Pouliot, K. Shinohara, M. Roach III Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 6 10